Analysts rate K2M shares: 5 facts

Spinal Tech

Seven firms gave K2M shares a consensus recommendation of "buy," according to web breaking news.

Here are five facts:

 

1. The shares have an average one-year price target of $25.50.

 

2. K2M Director Carlos A. Ferrer purchased 38,924 company shares for a total value of nearly $500,015.

 

3. Dr. Ferrer currently owns 39,383 K2M shares.

 

4. On April 26, K2M shares opened at $16.75.

 

5. The market cap is $690.57 million.

 

More device news:
Wenzel Spine's VariLift-LX on full US commercial launch: 5 key notes
4th patient in INSPIRE study experiences AIS grade improvement: 5 things to know
Life Spine to host physician workshop for new solutions launching in 2016 — 3 highlights

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers